|
1
|
Clavien PA, Lesurtel M, Bossuyt PM, Gores
GJ, Langer B and Perrier A; OLT for HCC Consensus Group, :
Recommendations for liver transplantation for hepatocellular
carcinoma: An international consensus conference report. Lancet
Oncol. 13:e11–e22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Poon D, Anderson BO, Chen LT, Tanaka K,
Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, et al:
Management of hepatocellular carcinoma in Asia: Consensus statement
from the Asian Oncology Summit 2009. Lancet Oncol. 10:1111–1118.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai SH, Lu SX, Liu LL, Zhang CZ and Yun
JP: Increased expression of hepatocyte nuclear factor 4 alpha
transcribed by promoter 2 indicates a poor prognosis in
hepatocellular carcinoma. Therap Adv Gastroenterol. 10:761–771.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ou H, Cai S, Liu Y, Xia M and Peng J: A
noninvasive diagnostic model to assess nonalcoholic hepatic
steatosis in patients with chronic hepatitis B. Therap Adv
Gastroenterol. 10:207–217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friemel J, Rechsteiner M, Frick L, Böhm F,
Struckmann K, Egger M, Moch H, Heikenwalder M and Weber A:
Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer
Res. 21:1951–1961. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu X, Cai S, Li Z, Zheng C, Xue X, Zeng J
and Peng J: Potential effects of telbivudine and entecavir on renal
function: A systematic review and meta-analysis. Virol J.
13:642016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cai S, Ou Z, Liu D, Liu L, Liu Y, Wu X, Yu
T and Peng J: Risk factors associated with liver steatosis and
fibrosis in chronic hepatitis B patient with component of metabolic
syndrome. United European Gastroenterol J. 6:558–566. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeng J, Cai S, Liu J, Xue X, Wu X and
Zheng C: Dynamic changes in liver stiffness measured by transient
elastography predict clinical outcomes among patients with chronic
Hepatitis B. J Ultrasound Med. 36:261–268. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
CD36-mediated lipid metabolism promotes
metastasis. Cancer Discov. 7:F122017. View Article : Google Scholar
|
|
11
|
Xiao YB, Cai SH, Liu LL, Yang X and Yun
JP: Decreased expression of peroxisome proliferator-activated
receptor alpha indicates unfavorable outcomes in hepatocellular
carcinoma. Cancer Manag Res. 10:1781–1789. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z and Kang Y: Lipid metabolism fuels
cancer's spread. Cell Metab. 25:228–230. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nieman KM, Kenny HA, Penicka CV, Ladanyi
A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB,
Hotamisligil GS, et al: Adipocytes promote ovarian cancer
metastasis and provide energy for rapid tumor growth. Nat Med.
17:1498–1503. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pascual G, Avgustinova A, Mejetta S,
Martín M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A,
Hueto JA, et al: Targeting metastasis-initiating cells through the
fatty acid receptor CD36. Nature. 541:41–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sunami Y, Rebelo A and Kleeff J: Lipid
metabolism and lipid droplets in pancreatic cancer and stellate
cells. Cancers (Basel). 10(pii): E32017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta S, Santra L, Naskar S, Maurya SK,
Rana M, Ghosh J and Dhara SK: Heterologous expression of porcine
elongase 6 (ELOVL6) gene in a human cell line. Indian J Med Res.
145:563–568. 2017.PubMed/NCBI
|
|
17
|
Su YC, Feng YH, Wu HT, Huang YS, Tung CL,
Wu P, Chang CJ, Shiau AL and Wu CL: Elovl6 is a negative clinical
predictor for liver cancer and knockdown of Elovl6 reduces murine
liver cancer progression. Sci Rep. 8:65862018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng YH, Chen WY, Kuo YH, Tung CL, Tsao
CJ, Shiau AL and Wu CL: Elovl6 is a poor prognostic predictor in
breast cancer. Oncol Lett. 12:207–212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamashita Y, Nishiumi S, Kono S, Takao S,
Azuma T and Yoshida M: Differences in elongation of very long chain
fatty acids and fatty acid metabolism between triple-negative and
hormone receptor-positive breast cancer. BMC Cancer. 17:5892017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bosquet A, Guaita-Esteruelas S, Saavedra
P, Rodríguez-Calvo R, Heras M, Girona J and Masana L: Exogenous
FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.
Atherosclerosis. 249:191–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Horie Y, Suzuki A, Kataoka E, Sasaki T,
Hamada K, Sasaki J, Mizuno K, Hasegawa G, Kishimoto H, Iizuka M, et
al: Hepatocyte-specific Pten deficiency results in steatohepatitis
and hepatocellular carcinomas. J Clin Invest. 113:1774–1783. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai SH, Lv FF, Zhang YH, Jiang YG and Peng
J: Dynamic comparison between Daan real-time PCR and Cobas TaqMan
for quantification of HBV DNA levels in patients with CHB. BMC
Infect Dis. 14:852014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai S, Cao J, Yu T, Xia M and Peng J:
Effectiveness of entecavir or telbivudine therapy in patients with
chronic hepatitis B virus infection pre-treated with interferon
compared with de novo therapy with entecavir and telbivudine.
Medicine (Baltimore). 96:e70212017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen WX, Cheng L, Xu LY, Qian Q and Zhu
YL: Bioinformatics analysis of prognostic value of TRIM13 gene in
breast cancer. Biosci Rep. 39(pii): BSR201902852019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li C, Zhou D, Jiang X, Liu M, Tang H and
Mei Z: Identifying hepatocellular carcinoma-related hub genes by
bioinformatics analysis and CYP2C8 is a potential prognostic
biomarker. Gene. 698:9–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsochatzis EA, Meyer T and Burroughs AK:
Hepatocellular carcinoma. N Engl J Med. 366:92–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
White DL, Thrift AP, Kanwal F, Davila J
and El-Serag HB: Incidence of hepatocellular carcinoma in All 50
United States, From 2000 Through 2012. Gastroenterology.
152:812–820.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai S, Li Z, Yu T, Xia M and Peng J: Serum
hepatitis B core antibody levels predict HBeAg seroconversion in
chronic hepatitis B patients with high viral load treated with
nucleos(t)ide analogs. Infect Drug Resist. 11:469–477. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai S, Yu T, Jiang Y, Zhang Y, Lv F and
Peng J: Comparison of entecavir monotherapy and de novo lamivudine
and adefovir combination therapy in HBeAg-positive chronic
hepatitis B with high viral load: 48-week result. Clin Exp Med.
16:429–436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Calvisi DF, Wang C, Ho C, Ladu S, Lee SA,
Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, et al:
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling,
promotes development of human hepatocellular carcinoma.
Gastroenterology. 140:1071–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao D, Song X, Che L, Li X, Pilo MG,
Vidili G, Porcu A, Solinas A, Cigliano A, Pes GM, et al: Both de
novo synthetized and exogenous fatty acids support the growth of
hepatocellular carcinoma cells. Liver Int. 37:80–89. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Caro P, Kishan AU, Norberg E, Stanley IA,
Chapuy B, Ficarro SB, Polak K, Tondera D, Gounarides J, Yin H, et
al: Metabolic signatures uncover distinct targets in molecular
subsets of diffuse large B cell lymphoma. Cancer Cell. 22:547–560.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Al-Bahlani S, Al-Lawati H, Al-Adawi M,
Al-Abri N, Al-Dhahli B and Al-Adawi K: Fatty acid synthase
regulates the chemosensitivity of breast cancer cells to
cisplatin-induced apoptosis. Apoptosis. 22:865–876. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sczaniecka AK, Brasky TM, Lampe JW,
Patterson RE and White E: Dietary intake of specific fatty acids
and breast cancer risk among postmenopausal women in the VITAL
cohort. Nutr Cancer. 64:1131–1142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao F, Wang C, Yin H, Yu J, Chen S, Fang
J and Guo F: Leucine deprivation inhibits proliferation and induces
apoptosis of human breast cancer cells via fatty acid synthase.
Oncotarget. 7:63679–63689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hoekstra M, van der Sluis RJ, Kuiper J and
Van Berkel TJ: Nonalcoholic fatty liver disease is associated with
an altered hepatocyte microRNA profile in LDL receptor knockout
mice. J Nutr Biochem. 23:622–628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moon YA, Ochoa CR, Mitsche MA, Hammer RE
and Horton JD: Deletion of ELOVL6 blocks the synthesis of oleic
acid but does not prevent the development of fatty liver or insulin
resistance. J Lipid Res. 55:2597–2605. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kessler SM, Simon Y, Gemperlein K,
Gianmoena K, Cadenas C, Zimmer V, Pokorny J, Barghash A, Helms V,
van Rooijen N, et al: Fatty acid elongation in non-alcoholic
steatohepatitis and hepatocellular carcinoma. Int J Mol Sci.
15:5762–5773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Crowe FL, Allen NE, Appleby PN, Overvad K,
Aardestrup IV, Johnsen NF, Tjønneland A, Linseisen J, Kaaks R,
Boeing H, et al: Fatty acid composition of plasma phospholipids and
risk of prostate cancer in a case-control analysis nested within
the European Prospective Investigation into Cancer and Nutrition.
Am J Clin Nutr. 88:1353–1363. 2008.PubMed/NCBI
|
|
40
|
Di Gangi IM, Mazza T, Fontana A, Copetti
M, Fusilli C, Ippolito A, Mattivi F, Latiano A, Andriulli A,
Vrhovsek U and Pazienza V: Metabolomic profile in pancreatic cancer
patients: A consensus-based approach to identify highly
discriminating metabolites. Oncotarget. 7:5815–5829. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bougnoux P, Hajjaji N, Ferrasson MN,
Giraudeau B, Couet C and Le Floch O: Improving outcome of
chemotherapy of metastatic breast cancer by docosahexaenoic acid: A
phase II trial. Br J Cancer. 101:1978–1985. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Baek JS and Cho CW:
2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for
overcoming p-glycoprotein function in multidrug-resistant breast
cancer cells. J Pharm Pharmacol. 65:72–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cao W, Ma Z, Rasenick MM, Yeh S and Yu J:
N-3 poly-unsaturated fatty acids shift estrogen signaling to
inhibit human breast cancer cell growth. PLoS One. 7:e528382012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Conceicao LL, Dias MM, Pessoa MC, Pena GD,
Mendes MC, Neves CV, Hermsdorff HH, Freitas RN and Peluzio MD:
Difference in fatty acids composition of breast adipose tissue in
women with breast cancer and benign breast disease. Nutr Hosp.
33:1354–1360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kikuchi M, Shimada M, Matsuzaka T, Ishii
K, Nakagawa Y, Takayanagi M, Yamada N and Shimano H: Crucial role
of Elovl6 in chondrocyte growth and differentiation during growth
plate development in mice. PLoS One. 11:e1593752016. View Article : Google Scholar
|
|
46
|
Anelli L, Zagaria A, Coccaro N, Tota G,
Impera L, Minervini CF, Pastore D, Minervini A, Casieri P, Specchia
G and Albano F: A novel t(4;16)(q25;q23.1) associated with EGF and
ELOVL6 deregulation in acute myeloid leukemia. Gene. 529:144–147.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen Q, Wang D, Li Y, Yan S, Dang H, Yue
H, Ling J, Chen F, Zhao Y, Gou L, et al: LINC00628 suppresses
migration and invasion of hepatocellular carcinoma by its conserved
region interacting with the promoter of VEGFA. J Cell Physiol. Feb
10–2019.doi: 10.1002/jcp.28233 (Epub ahead of print).
|
|
48
|
Cheng SY, Chen NF, Lin PY, Su JH, Chen BH,
Kuo HM, Sung CS, Sung PJ, Wen ZH and Chen WF: Anti-invasion and
Antiangiogenic effects of Stellettin B through inhibition of the
Akt/Girdin signaling pathway and VEGF in Glioblastoma cells.
Cancers (Basel). 11(pii): E2202019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen SH, Zhang BY, Zhou B, Zhu CZ, Sun LQ
and Feng YJ: Perineural invasion of cancer: A complex crosstalk
between cells and molecules in the perineural niche. Am J Cancer
Res. 9:1–21. 2019.PubMed/NCBI
|
|
50
|
Labib PL, Goodchild G and Pereira SP:
Molecular pathogenesis of cholangiocarcinoma. BMC Cancer.
19:1852019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lu JB, Cai SH, Pan YH and Yun JP: Altered
epidermal fatty acid-binding protein expression in hepatocellular
carcinoma predicts unfavorable outcomes. Cancer Manag Res.
10:6275–6284. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li FJ, Wang HY, Feng XL, Li PP, Shu T,
Zhao XH and Li B: Expression and clinical significance of ELOVL6
gene in high-grade serous ovarian carcinoma. Zhonghua Fu Chan Ke Za
Zhi. 51:192–197. 2016.(In Chinese). PubMed/NCBI
|
